Folks with "high-risk" bladder cancers -- tumors that had already invaded nearby muscle -- doubled the time they were ...

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and ...

BARCELONA — Adding the immune checkpoint inhibitor durvalumab to standard treatment for muscle-invasive bladder cancer (MIBC) ...

An AstraZeneca immunotherapy improved survival rates in patients with bladder cancer, results that could reshape treatment of ...

A mum from Hadleigh in Suffolk who discovered she had bladder cancer in a scan is to raise money for Cancer Research UK by ...

AstraZeneca Plc’s Imfinzi extended the lives of patients with bladder cancer, potentially opening up a new market for the ...

Trodelvy in locally advanced or metastatic urothelial cancer may provide another option for those whose disease progressed ...

AstraZeneca’s Phase 3 study in bladder cancer, showed that giving Imfinzi — before and after surgery — cut the risk of death.

AstraZeneca’s Imfinzi recently became the first PD-1/L1 inhibitor to deliver a patient survival win in muscle-invasive ...

Some 10,000 Britons are diagnosed with bladder cancer every year, and experts warn the public is still unaware of the ...

Researchers compared health-related quality of life with nivolumab added to first-line chemo vs chemo alone in patients with ...

Janine Edgar, from Suffolk, discovered she had bladder cancer when a growth was spotted at the 20-week ultrasound scan for ...